Market Updates
Software and Pharma Exporters Lead Sensex Advance in Mumbai
Mukesh Buch
19 Aug, 2015
New York City
-
Generic drug makers and software services exporters led the gainers in Mumbai trading. DLF plans to sell its land parcel in Kochi. ICICI Bank acquired 9% stake in Karuturi Global. Tata Elxsi profit surged 71% on 28% increase in revenues.
[R]6:00 PM Mumbai – Generic drug makers and software services exporters led the gainers in Mumbai trading. DLF plans to sell its land parcel in Kochi. ICICI Bank acquired 9% stake in Karuturi Global. Tata Elxsi profit surged 71% on 28% increase in revenues.[/R]
Stocks in Mumbai rebounded after two days of losses and pharmaceuticals and software exporters led the gainers on the expectations of rising sales.
Rupee strengthened 5 paisa to 65.26 against one U.S. dollar.
The Sensex Index increased 100.10 or 0.4% to close at 27,931.64. The CNX Nifty rose 28.60 or 0.4% to 8,495.15.
Gainers & Losers
Aurobindo Pharma Ltd jumped 4.3% to ₹823.50 after the natural and ayurvedic medicine maker plans to construct three formulation plants in Andhra Pradesh and Telangana.
DLF Limited fell 0.7% to ₹127.10 after the real estate developer plans to sell its land parcel in Kochi for about ₹111 crore.
Glenmark Pharmaceuticals Ltd. gained 3.4% to ₹1,200.45 after the generic drug maker received approval from the U.S. Food & Drug Administration for the sale of generic version of Bayer’s Yaz contraceptive tablets.
Infosys Limited rose 0.9% to ₹1,175.05 after the software developer received an order from the Fidelity Bank of Nigeria to upgrade its core banking platform.
Jindal Saw Limited decreased 1.6% to ₹77.10 after the company received shareholders’ approval to raise up to ₹3,000 crore.
Karuturi Global Limited declined 4.9% to ₹3.10 after the florist said that the ICICI Bank acquired 8.89% stake in the company for ₹25 crore.
Tata Elxsi Limited advanced 2.9% to ₹2,193.05 after net in the first-quarter surged 71% to ₹35.72 crore.
Total revenues in the quarter jumped 27.7% to ₹24.35 crore.
Annual Returns
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|